Ignite Creation Date:
2025-12-24 @ 12:07 PM
Ignite Modification Date:
2026-02-07 @ 3:48 PM
Study NCT ID:
NCT05144061
Status:
COMPLETED
Last Update Posted:
2024-12-18
First Post:
2021-10-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-human Study of HRS2398 Tablets in Subjects With Advanced Malignant Tumors
Sponsor:
Shanghai Hengrui Pharmaceutical Co., Ltd.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Advanced Malignant Tumor | View |
Keywords: